Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma – a retrospective study using TCGA database

Citations Over TimeTop 1% of 2019 papers

Abstract

m6A is the most common form of mRNA modification. However, little is known about its role in clear cell renal cell carcinoma (ccRCC). This study aims to identify gene signatures and prognostic values of m6A regulators in ccRCC. In this study, a total of 528 ccRCC patients from TCGA database with sequencing and CNV data were included. Survival analysis was performed using log-rank tests and Cox regression model. The association between alteration of m6A regulators and clinicopathological characteristics was examined using chi-square test. The results showed that alteration of m6A regulators was associated with pathologic stage. Patients with any CNVs of the regulatory genes had worse OS and DFS than those with diploid genes. Moreover, deletion of m6A "writer" genes was an independent risk factor for OS, and copy number gain of "eraser" genes could magnify the effect in a synergistic way. Additionally, low expression of the writer gene METTL3 was related to activations of adipogenesis and mTOR pathways. Thus, we for the first time determined genetic alterations of m6A regulators in ccRCC and found a significant relationship between the alterations and worse clinical characteristics. The findings provide us clues to understand epigenetic modification of RNA in ccRCC.

Related Papers

• → NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma(2017)25 cited
• → Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma(2017)16 cited
• → A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma(2021)13 cited
• → A prognostic index model for assessing the prognosis of ccRCC patients by using the mRNA expression profiles of AIF1L, SERPINC1 and CES1(2022)1 cited
• → Basement membrane genes can predict the prognosis of patients with clear cell renal cell carcinoma (ccRCC) and are correlated with immune status(2022)2 cited